Investigator-initiated Trials And Research Collaborations Symposium

16th investigator initiated trials conference

DEPOSIT NAME
16th investigator initiated trials conference
CATEGORY
Annuities
POPULARITY
42/100

Description

Summit to learn how to streamline and expand your IISR programs to maximize clinical results. Don’t miss this timely opportunity to hear important updates on the globalization of government funded clinical trials in oncology. IIT portfolio management taking into consideration financial, logistical and regulatory/legal aspects. IITs, including responsibilities; ownership of the research, royalties and publication rights; and, most crucially, when it’s viable and appropriate to support each type of collaboration. Pharmaceutical & Medical Device manufacturers are eagerly working with outside investigators in order to further the knowledge and understanding of the potential uses for their products, through the conduct of investigator initiated research studies. While these studies provide invaluable data and insight into existing products, they are also an expensive undertaking and can at times cause significant strain on the manufacturer as investigators demand additional support and funds to continue research. Compounding these challenges are increasing regulatory reporting requirements and pressure from governing bodies related to the relationships between industry and healthcare professionals. Studies Conference will provide attendees with an opportunity to discuss and debate the many challenges faced by medical affairs teams as they look to not only maximize the research and outcomes from these exciting studies, but also minimize risks and costs. Processes for maintaining the IIT quality life cycle and ensuring results, The effects of an organization’s brand and business strategy on IIS selection, Best practices for clinical trial contracting. Initiated Trials (IITs), also referred to as Sponsor-Investigator (SI) Trials are increasing in popularity. Annual MSL Best Practices Conference and the 3rd Medical Affairs Executive Forum which allows for exceptional networking opportunities to discuss best practices and share newly learned information. The presenters will guide audience members through a series of exercises to develop tactics for addressing the immediate issues and plans for avoiding problems in the future.